Abstract
Paragangliomas are rare tumors that arise from neural crest cells occurring at an incidence of between 1 in 30,000 and 1 in 100,000 (Papaspyrou et al, Head Neck-J Sci Spec 34(5):632–637, 2012). Ninety percent of these tumors occur in the adrenal paraganglia and are termed pheochromocytoma (Moore et al, Otolaryngol Head Neck Surg 154(4):597–605, 2016). Among the paragangliomas that occur outside of the adrenal gland, 85% are located in the abdomen, 12% in the thorax, and 3% in the head and neck (Moore et al, Otolaryngol Head Neck Surg 154(4):597–605, 2016). The carotid bifurcation is the most common paraganglioma tumor subsite within the head and neck, accounting for 60–78% of head and neck paragangliomas (Abu-Ghanem et al, Head Neck 38(Suppl 1):E2386–2394, 2016). Paragangliomas of the head and neck can also arise from other sites, including the jugulotympanic region, vagus nerve, sympathetic trunk, laryngeal paraganglia, ciliary ganglion, nasal cavity, and paranasal sinuses (Piccini et al, Endocr-Relat Cancer 9(2):149–155, 2012; Langerman et al, Head Neck 35(7):930–933, 2013). Head and neck paragangliomas are typically parasympathetic in origin and non-secreting (non-chromaffin paragangliomas); only 3–5% hypersecrete catecholamines (Suarez et al, Head Neck 35(8):1195–1204, 2013). Paragangliomas can either be hereditary or sporadic. When hereditary, gene mutations are usually found in the succinate dehydrogenase or mitochondrial complex II genes (Piccini et al, Endocr-Relat Cancer 9(2):149–155, 2012). Most sporadic paragangliomas present as a single tumor, with only 10–20% demonstrating multifocality. However, familial paragangliomas are multifocal in up to 80% of cases (Lee et al, Cancer 94(3):730–737, 2002). This chapter will focus on head and neck paraganglioma of the lateral cervical region, specifically carotid body and vagal paragangliomas.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
***Papaspyrou K, Mewes T, Rossmann H, et al. Head and neck paragangliomas: report of 175 patients (1989–2010). Head Neck-J Sci Spec. 2012;34(5):632–7.
Moore MG, Netterville JL, Mendenhall WM, Isaacson B, Nussenbaum B. Head and neck paragangliomas: an update on evaluation and management. Otolaryngol Head Neck Surg. 2016;154(4):597–605.
***Abu-Ghanem S, Yehuda M, Carmel NN, Abergel A, Fliss DM. Impact of preoperative embolization on the outcomes of carotid body tumor surgery: a meta-analysis and review of the literature. Head Neck. 2016;38(Suppl 1):E2386–94.
***Piccini V, Rapizzi E, Bacca A, et al. Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients. Endocr-Relat Cancer. 2012;19(2):149–55.
Langerman A, Rangarajan SV, Athavale SM, Pham MQ, Sinard RJ, Netterville JL. Tumors of the cervical sympathetic chain – diagnosis and management. Head Neck. 2013;35(7):930–3.
***Suarez C, Rodrigo JP, Bodeker CC, et al. Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy. Head Neck. 2013;35(8):1195–204.
***Lee JH, Barich F, Karnell LH, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002;94(3):730–7.
Som PM, Sacher M, Stollman AL, Biller HF, Lawson W. Common tumors of the parapharyngeal space – refined imaging diagnosis. Radiology. 1988;169(1):81–5.
Wax MK, Shiley SG, Robinson JL, Weissman JL. Cervical sympathetic chain schwannoma. Laryngoscope. 2004;114(12):2210–3.
***El-Rabadi K, Weber M, Mayerhofer M, et al. Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/contrast-enhanced computed tomography (18F-DOPA PET/CT) in patients with suspected Paraganglioma. Anticancer Res. 2016;36(8):4187–93.
Hoegerle S, Ghanem N, Altehoefer C, et al. 18F-DOPA positron emission tomography for the detection of glomus tumours. Eur J Nucl Med Mol Imaging. 2003;30(5):689–94.
Melmed S, Williams RH. Endocrine hypertension. 12th ed. Philadelphia: Elsevier/Saunders; 2011.
Knight TT Jr, Gonzalez JA, Rary JM, Rush DS. Current concepts for the surgical management of carotid body tumor. Am J Surg. 2006;191(1):104–10.
Lahiri S, Di Giulio C, Roy A. Lessons from chronic intermittent and sustained hypoxia at high altitudes. Respir Physiol Neurobiol. 2002;130(3):223–33.
Kemp PJ, Lewis A, Hartness ME, et al. Airway chemotransduction: from oxygen sensor to cellular effector. Am J Respir Crit Care Med. 2002;166(12 Pt 2):S17–24.
Baysal BE, Myers EN. Etiopathogenesis and clinical presentation of carotid body tumors. Microsc Res Tech. 2002;59(3):256–61.
Maxwell JG, Jones SW, Wilson E, et al. Carotid body tumor excisions: adverse outcomes of adding carotid endarterectomy. J Am Coll Surg. 2004;198(1):36–41.
Lack EE. Anatomy and physiology of peripheral arterial chemoreceptors. Philadelphia: W.B. Saunders; 1994.
McNichol AM. Differential diagnosis of pheochromocytomas and paragangliomas. Endocr Pathol. 2001;12(4):407–15.
Min KW. Diagnostic usefulness of sustentacular cells in paragangliomas: immunocytochemical and ultrastructural investigation. Ultrastruct Pathol. 1998;22(5):369–76.
Achilles E, Padberg BC, Holl K, Kloppel G, Schroder S. Immunocytochemistry of paragangliomas – value of staining for S-100 protein and glial fibrillary acid protein in diagnosis and prognosis. Histopathology. 1991;18(5):453–8.
Arias-Stella J, Valcarcel J. The human carotid body at high altitudes. Pathol Microbiol (Basel). 1973;39(3):292–7.
Edwards C, Heath D, Harris P, Castillo Y, Kruger H, Arias-Stella J. The carotid body in animals at high altitude. J Pathol. 1971;104(4):231–8.
*Rodriguez-Cuevas S, Lopez-Garza J, Labastida-Almendaro S. Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level. Head Neck. 1998;20(5):374–8.
Neumann HP, Pawlu C, Peczkowska M, et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. JAMA. 2004;292(8):943–51.
Martin TP, Irving RM, Maher ER. The genetics of paragangliomas: a review. Clin Otolaryngol. 2007;32(1):7–11.
***Boedeker CC, Erlic Z, Richard S, et al. Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 2009;94(6):1938–44.
Burnichon N, Rohmer V, Amar L, et al. The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. J Clin Endocrinol Metab. 2009;94(8):2817–27.
Mannelli M, Castellano M, Schiavi F, et al. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab. 2009;94(5):1541–7.
Lima J, Feijao T, Ferreira da Silva A, et al. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations. J Clin Endocrinol Metab. 2007;92(12):4853–64.
***Langerman A, Athavale SM, Rangarajan SV, Sinard RJ, Netterville JL. Natural history of cervical paragangliomas: outcomes of observation of 43 patients. Arch Otolaryngol Head Neck Surg. 2012;138(4):341–5.
**Jansen JC, van den Berg R, Kuiper A, van der Mey AG, Zwinderman AH, Cornelisse CJ. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer. 2000;88(12):2811–6.
Lim JY, Kim J, Kim SH, et al. Surgical treatment of carotid body paragangliomas: outcomes and complications according to the shamblin classification. Clin Exp Otorhinolaryngol. 2010;3(2):91–5.
Kruger AJ, Walker PJ, Foster WJ, Jenkins JS, Boyne NS, Jenkins J. Important observations made managing carotid body tumors during a 25-year experience. J Vasc Surg. 2010;52(6):1518–23.
Del Guercio L, Narese D, Ferrara D, Butrico L, Padricelli A, Porcellini M. Carotid and vagal body paragangliomas. Transl Med UniSa. 2013;6:11–5.
Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma). Clinicopathologic analysis of ninety cases. Am J Surg. 1971;122(6):732–9.
*Dardik A, Eisele DW, Williams GM, Perler BA. A contemporary assessment of carotid body tumor surgery. Vasc Endovasc Surg. 2002;36(4):277–83.
*Power AH, Bower TC, Kasperbauer J, et al. Impact of preoperative embolization on outcomes of carotid body tumor resections. J Vasc Surg. 2012;56(4):979–89.
Tasar M, Yetiser S. Glomus tumors: therapeutic role of selective embolization. J Craniofac Surg. 2004;15(3):497–505.
Hu K, Persky MS. The multidisciplinary management of paragangliomas of the head and neck, part 2. Oncology (Williston Park). 2003;17(8):1143–53; discussion 1154, 1158, 1161.
***Hinerman RW, Amdur RJ, Morris CG, Kirwan J, Mendenhall WM. Definitive radiotherapy in the management of paragangliomas arising in the head and neck: a 35-year experience. Head Neck. 2008;30(11):1431–8.
**Gilbo P, Tariq A, Morris CG, Mendenhall WM. External-beam radiation therapy for malignant paraganglioma of the head and neck. Am J Otolaryngol. 2015;36(5):692–6.
**Bradshaw JW, Jansen JC. Management of vagal paraganglioma: is operative resection really the best option? Surgery. 2005;137(2):225–8.
Disclosure Statement
None of the authors have any commercial or financial conflicts of interest, and no external funding sources were obtained.
To assist the reader in gaining familiarity with available evidence, the following rating system has been used to indicate key references for each chapter’s content:
***: Critical material. Anyone dealing with this condition should be familiar with this reference.
**: Useful material. Important information that is valuable in in clinical or scientific practice related to this condition.
*: Optional material. For readers with a strong interest in the chapter content or a desire to study it in greater depth.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Marston, A.P., Moore, E. (2018). Cervical Paraganglioma. In: Perkins, J., Balakrishnan, K. (eds) Evidence-Based Management of Head and Neck Vascular Anomalies. Springer, Cham. https://doi.org/10.1007/978-3-319-92306-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-92306-2_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-92305-5
Online ISBN: 978-3-319-92306-2
eBook Packages: MedicineMedicine (R0)